Etretinate treatment of the nevoid basal cell carcinoma syndrome. Therapeutic and chemopreventive effect.

Abstract

A patient suffering from the nevoid basal cell carcinoma syndrome, in whom various surgical and conservative treatment modalities had been tried previously, was placed on oral etretinate therapy. A therapeutic effect of the etretinate on existing basal cell carcinomas and a prophylactic effect in inhibiting new tumor formation were well demonstrated during the 13-month period of treatment.

• Authors: E Hodak, A Ginzburg, M David, M Sandbank
• Journal: International journal of dermatology (Int J Dermatol) Vol. 26 Issue 9 Pg. 606-9 (Nov 1987) ISSN: 0011-9059 [Print] England
• PMID: 3443534 (Publication Type: Case Reports, Journal Article)

Chemical References

• Etretinate

Topics

• Basal Cell Nevus Syndrome (drug therapy, prevention & control)
• Carcinoma, Basal Cell (drug therapy)
• Etretinate (therapeutic use)
• Humans
• Male
• Middle Aged